Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity …
F Lopez-Jimenez, W Almahmeed… - European journal of …, 2022 - academic.oup.com
The ongoing obesity epidemic represents a global public health crisis that contributes to
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …
Inflammatory cells in atherosclerosis
M Mehu, CA Narasimhulu, DK Singla - Antioxidants, 2022 - mdpi.com
Atherosclerosis is a chronic progressive disease that involves damage to the intima,
inflammatory cell recruitment and the accumulation of lipids followed by calcification and …
inflammatory cell recruitment and the accumulation of lipids followed by calcification and …
Efficient data-driven machine learning models for cardiovascular diseases risk prediction
Cardiovascular diseases (CVDs) are now the leading cause of death, as the quality of life
and human habits have changed significantly. CVDs are accompanied by various …
and human habits have changed significantly. CVDs are accompanied by various …
Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES …
SM Lopez-Neyman, K Davis, N Zohoori… - Scientific reports, 2022 - nature.com
This study estimated the prevalence of cardiovascular disease (CVD) risk factors,
cardiometabolic (CM) risk factors, and cardiovascular health metrics (CVHMs) among US …
cardiometabolic (CM) risk factors, and cardiovascular health metrics (CVHMs) among US …
[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022
HE Bays, A Agarwala, C German, P Satish… - American Journal of …, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding …
about ten cardiovascular disease risk factors–2022" is a summary document regarding …
2022 ACC/AHA key data elements and definitions for chest pain and acute myocardial infarction: a report of the American Heart Association/American College of …
HV Anderson, SC Masri, MS Abdallah… - … Quality and Outcomes, 2022 - Am Heart Assoc
HV (“Skip”) Anderson, MD, FACC, FAHA, Chair*; Sofia Carolina Masri, MD, Vice Chair;
Mouin S. Abdallah, MD, MHCM, MSc, FACC; Anna Marie Chang, MD, MSCE†; Mauricio G …
Mouin S. Abdallah, MD, MHCM, MSc, FACC; Anna Marie Chang, MD, MSCE†; Mauricio G …
Tackling atherosclerosis via selected nutrition
A Vesnina, A Prosekov, V Atuchin, V Minina… - International journal of …, 2022 - mdpi.com
The development and pathogenesis of atherosclerosis are significantly influenced by
lifestyle, particularly nutrition. The modern level of science and technology development …
lifestyle, particularly nutrition. The modern level of science and technology development …
Obesity and cardiovascular risk: systematic intervention is the key for prevention
Obesity is a serious public health issue and associated with an increased risk of
cardiovascular disease events and mortality. The risk of cardiovascular complications is …
cardiovascular disease events and mortality. The risk of cardiovascular complications is …
[HTML][HTML] An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management
MR Abouzid, K Ali, I Elkhawas, SM Elshafei - Cureus, 2022 - ncbi.nlm.nih.gov
In Egypt, diabetes mellitus (DM) is a significant public health concern, and the disease is
considered a modern pandemic throughout the world. The incidence of diabetes is steadily …
considered a modern pandemic throughout the world. The incidence of diabetes is steadily …
[HTML][HTML] Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022
HE Bays, A Fitch, S Christensen, K Burridge, J Tondt - Obesity Pillars, 2022 - Elsevier
Abstract Background This “Anti-Obesity Medications and Investigational Agents: An Obesity
Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an …
Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an …